Table 1. Correlation of clinicopathological parameters and TACC3 expression.
Variable | TACC3 expression | |||
---|---|---|---|---|
All cases | Low expression | High expression | P valuea | |
Age (years)b | 0.546 | |||
< 53 | 63 | 31 (49.2%) | 32 (50.8%) | |
≥ 53 | 98 | 53 (54.1%) | 45 (45.9%) | |
Gender | 0.989 | |||
Female | 71 | 37 (52.1%) | 34 (47.9%) | |
Male | 90 | 47 (52.2%) | 43 (47.8%) | |
Clinical Stage | 0.045 | |||
I+II | 65 | 40 (61.5%) | 25 (38.5%) | |
III | 69 | 35 (50.7%) | 34 (49.3%) | |
IV | 27 | 9 (33.3%) | 18 (66.7%) | |
T classification | 0.029 | |||
T1+T2 | 33 | 14 (42.4%) | 19 (57.6%) | |
T3 | 40 | 28 (70%) | 12 (30%) | |
T4 | 88 | 42 (47.7%) | 46 (52.3%) | |
N classification | 0.447 | |||
N0 | 71 | 41 (57.7%) | 30 (42.3%) | |
N+ | ||||
M classification | 0.020 | |||
M0 | 133 | 75 (56.4%) | 58 (43.6%) | |
M1 | 28 | 9 (32.1%) | 19 (67.9%) | |
Pathologic Differentiation | 0.549 | |||
Well | 3 | 1 (33.3%) | 2 (66.7%) | |
Moderately | 150 | 80 (53.3%) | 70 (46.7%) | |
Poorly | 8 | 3 (37.5%) | 5 (62.5%) | |
Histological Types | 0.865 | |||
Non-mucinous adenocarcinoma | 147 | 77 (52.3%) | 70 (47.7%) | |
mucinous adenocarcinoma | 14 | 7 (50.0%) | 7 (50.0%) | |
Location | 0.267 | |||
Colon | 93 | 52 (55.9%) | 41 (44.1%) | |
Rectal | 68 | 32 (47.1%) | 36 (52.9%) | |
Vital status | 0.058 | |||
Alive | 108 | 62 (57.4%) | 46 (42.6%) | |
Death | 53 | 22 (41.5%) | 31 (58.5%) |
Chi-square test;
Median age.